AI IntelligenceMar 17, 2026Secondary Market
Article
国药一致
China National Accord Medicines released a preliminary 2025 performance report. Revenue slightly declined 1.29% to RMB 73.416 billion, but net profit surged 76.8% to RMB 1.136 billion. Basic earnings per share were RMB 2.04.
Data Cube AI EditorialSource: 36Kr
01
Source Brief
China National Accord Medicines released a preliminary 2025 performance report. Revenue slightly declined 1.29% to RMB 73.416 billion, but net profit surged 76.8% to RMB 1.136 billion. Basic earnings per share were RMB 2.04.
02